Scientists hopeful for applications in people
A revolutionary gene therapy developed in Colorado could relieve people’s chronic pain, such as arthritis or fibromyalgia but first, it is being tested on pets with incredible results.
A Lafayette veterinarian is using cutting-edge research to heal dogs.
It may not look like it when 9-year-old Amos, a Labrador Retriever mix, is running happily after the ball, but he has arthritis, bad.
His owner, Vicki Riedel knew immediately.
“He is always by my side,” said Riedel. “When I would go outside or downstairs,and he wouldn’t come with me, I knew he was really hurting.”
Their vet tried one medication after the next.
“And they all helped a little bit, but none of them really helped a lot, and he seemed to be getting worse and worse,” said Riedel.
But a few weeks ago, Amos met pet pain specialist Dr. Rob Landry.
“Amos has a history of chronic pain in both his elbows,” said Landry, a Lafayette veterinarian who has been testing a breakthrough gene therapy for chronic pain for the last two years.
“It’s amazing,” said Laundry with a smile.
He’s injected 9 dogs, and so far he said the results speak for themselves.
In cell phone phone video of one dog before the injection, she hops with both back legs because of hip pain.
Just a week post-injection, she uses both legs.
And two months after, her owner said she is a different dog.
“I got into the field of pain to see these changes happen,” said Landry.
“It’s frankly revolutionary,” said Dr. Linda Watkins, who runs the neuroscience program at the University of Colorado. She started a biomedical company that makes the breakthrough therapeutic.
“It went from basic science, to ‘Wow! We got a shot at this,'” said Watkins.
Watkins said that in people with chronic pain, a type of immune cell in the spinal cord gets agitated, releasing signals that amplify pain.
Injecting her therapeutic creates a protein called Interleukin-10 (IL -10), which both dogs and humans produce naturally, and it seems to calm the agitated cells and reduce pain.
In testing on lab rats, it has been effective, but the work on dogs brings new hope.
“It’s not a rat thing. That we see it in the dogs and the dogs have pain relief for three months just like the rats did is really giving me hope that it’s going to translate all the way to people,” said Watkins.
So, the cutting-edge research helping man’s best friend could soon help man. Human clinical trials start in a year.
For pets, the timeline could be much shorter — if the research stays this positive, Landry believes it could be developed for vets within the next year or two.
The Latest Bing News on:
- Veterans look to alternatives to opioids in chronic pain treatmentson July 2, 2021 at 2:00 am
For some veterans and sufferers of chronic pain, treatments with opioids and narcotics have not been as effective as they had hoped. David Eggert, a Presque Isle resident who served in Afghanistan, ...
- This is what chronic pain looks like – in pictureson July 1, 2021 at 10:00 pm
Photographer Michaela Skovranova has lived with endometriosis for 20 years. This series of self-portraits shows the confronting reality of life with chronic pain ...
- Independence from Pain: World Institute of Pain Spotlights Advancements Helping Free Patients from Chronic Painon July 1, 2021 at 10:05 am
Across the United States, about 50 million adults experience chronic pain, according to an analysis of the National Health Interview Survey. On this I ...
- I suffer from three chronic conditions. The worst part is knowing my pain could have been preventedon June 30, 2021 at 9:01 pm
For years my pain was dismissed again and again by doctors who did not believe I was suffering ...
- Major research project to study chronic painon June 30, 2021 at 10:28 am
Chronic pain is a major global public health challenge that causes significant disability. A new research consortium and national chronic pain data hub could improve outcomes for the many people ...
- 3 ways managers can support employees living with chronic pain and fatigueon June 30, 2021 at 7:29 am
Make yourself approachable to discuss accommodations and recognize that not all chronic illnesses are visible.
- Total Health Chiropractic helps people in West Michigan get rid of chronic painon June 30, 2021 at 7:11 am
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting ...
- Say goodbye to chronic neck and back pain with treatments from Total Healthon June 30, 2021 at 6:25 am
Gardening, biking, and a nightly walk are just some of the things that get sidelined when someone has severe neck or back pain. Total Health Chiropractic offers treatments that promise to not only get ...
- ‘I struggle every day with the loss of my former life’: what it’s like to live with chronic painon June 30, 2021 at 1:18 am
The pain that can't be seen ‘I struggle every day with the loss of my former life’: what it’s like to live with chronic pain ...
- Eating This Type of Diet Increases Your Chronic Pain Risk, New Study Findson June 24, 2021 at 5:11 am
A common type of diet may increase your risk of chronic pain, especially if you have specific comorbidities, a new study finds.
The Latest Google Headlines on:
The Latest Bing News on:
Gene therapy for pain
- Roche to present new data at the ISTH 2021 Congress highlighting long-standing commitment to advancing haemophilia A standard of careon July 2, 2021 at 6:00 am
Roche will present the final analysis from the phase IIIb STASEY study, reinforcing the safety and efficacy profile of Hemlibra in a broad range of people with haemophilia A with factor VIII ...
- Gene editor injected into the body treats diseaseon July 1, 2021 at 2:20 pm
The gene editor CRISPR excels at fixing disease mutations in lab-grown cells. But using CRISPR to treat most people with genetic disorders requires clearing an enormous hurdle: getting the molecular ...
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo HSC Gene Therapy for Hereditary Angioedemaon July 1, 2021 at 3:38 am
Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, and Pharming Group N.V. (Euronext Amsterdam: PHARM) (Nasdaq: PHAR), ...
- Orchard Therapeutics and Pharming Group Announce...on June 30, 2021 at 10:00 pm
Highlights the broader potential of Orchard's ex vivo HSC gene therapy platform approach in new and larger indications Reinforces Pharming's commitment to the HAE community ...
- Biopharma financing digest—June 2021on June 30, 2021 at 5:00 pm
Emma Dorey explores the latest series B financing rounds from a range of several small biotech companies. Eliem Therapeutics Inc raised $60 million from new and old investors to develop novel ...
- MHRA grants bluebird bio’s LentiGlobin gene therapy an ‘innovation passport’on June 30, 2021 at 8:35 am
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted bluebird bio’s potential sickle cell disease gene therapy a new ‘innovation passport’. The Innovative Licensing and Access ...
- MHRA grants bluebird ‘innovation passport’ for sickle cell therapyon June 30, 2021 at 3:48 am
(CD) gene therapy LentiGlobin is the latest recipient of an ‘innovation passport’ introduced in the UK earlier this year to speed up NHS access to promising new medicines. The designation means that ...
- CRISPR therapy fights rare disease where protein clogs organson June 29, 2021 at 8:59 am
Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure.
- Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: surveyon June 29, 2021 at 7:55 am
Novartis’ Adakveo and Global Blood Therapeutics’ Oxbryta started their commercial life in 2019 as novel drugs for sickle cell disease. While physicians like their clinical profiles, formulary coverage ...
- ‘It’s a wow’: New CRISPR gene-editing success holds promise for treating many genetic diseases with a single doseon June 28, 2021 at 5:55 am
If the gene-editing tool CRISPR/Cas9 continues to show such promise it will herald a new era for the treatment of many genetic diseases.